Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer

Joseph H. Huntley, Rebecca Y. Coley, H. Ballentine Carter, Archana Radhakrishnan, Melinda Krakow, Craig E. Pollack

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To determine whether providing individualized predictions of health outcomes to men on active surveillance (AS) alleviates cancer-related anxiety and improves risk understanding. Materials and Methods: We consecutively recruited men from our large, institutional AS program before (n = 36) and after (n = 31) implementation of a risk prediction tool. Men in both groups were surveyed before and after their regular visits to assess their perceived cancer control, biopsy-specific anxiety, and burden from cancer-related information. We compared pre-/post-visit differences between men who were and were not shown the tool using two-sample t-tests. Satisfaction with and understanding of the predictions were elicited from men in the intervention period. Results: Men reported a relatively high level of cancer control at baseline. Men who were not shown the tool saw a 6.3 point increase (scaled from 0 to 100) in their perceived cancer control from before to after their visit whereas men who were shown the tool saw a 12.8 point increase, indicating a statistically significant difference between groups (p =.04). Biopsy-specific anxiety and burden from cancer information were not significantly different between groups. Men were satisfied with the tool and demonstrated moderate understanding. Conclusion: Providing individualized predictions to men on AS helps them better understand their cancer risk and should be considered at other clinical sites.

Original languageEnglish (US)
Pages (from-to)118-124
Number of pages7
JournalUrology
Volume121
DOIs
StatePublished - Nov 2018

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer'. Together they form a unique fingerprint.

Cite this